PresentationIt is now my pleasure to turn the call over to MBX Biosciences Senior Director of Investor Relations and Communications, Jim DeNike.Ladies and gentlemen, greetings, and welcome to MBX Biosciences Conference Call. Today's call is being recorded. [Operator Instructions] As a reminder, this conference is being recorded.Jim DeNike Thanks, Rob. Good morning, and thank you for joining us this morning to review the exciting top line results from our Avail Phase II clinical trial. I'm very pleased to re ...